374119-30-9Relevant academic research and scientific papers
N-Arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B
Greenspan, Paul D.,Clark, Kirk L.,Cowen, Scott D.,McQuire, Leslie W.,Tommasi, Ruben A.,Farley, David L.,Quadros, Elizabeth,Coppa, David E.,Du, Zengming,Fang, Zheng,Zhou, Huanghai,Doughty, John,Toscano, Karen T.,Wigg, Andrew M.,Zhou, Siyuan
, p. 4121 - 4124 (2007/10/03)
To improve the pharmacokinetics of a previously reported series of dipeptidyl nitrile cathepsin B inhibitors, the P2-P3 amide group was replaced with an arylamine. Further optimization of this template resulted in highly potent and s
N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
-
, (2008/06/13)
Compounds of the formula (I), wherein R1 is aryl or biaryl; R2 is aryl-lower alkyl, biaryl-lower alkyl, benzo-fused cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, aryloxy-lower alkyl, or aryl-C2-C7/sub
